part
anticanc
regimen
support
care
toxic
manag
outlin
guidanc
health
care
profession
assist
riskbenefit
analysi
corticosteroid
therapi
urooncolog
patient
pandem
case
fatal
rate
patient
cancer
report
twice
overal
fatal
rate
infect
vs
respons
heighten
presenc
shortcours
highdos
steroid
primari
antibodi
gener
seem
impair
advic
cdc
avoid
corticosteroid
base
concern
viral
replic
might
prolong
clearanc
delay
larg
